Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026)

Globus Medical (GMED) posted Total Non-Current Liabilities of $686.7 million for Q1 2026, down 3.04% on a QoQ basis from $708.2 million in Q4 2025, and up 35.97% year-over-year from $505.0 million in Q1 2025.

Globus Medical (GMED) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Globus Medical's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $686.7 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 35.97% year-over-year to $686.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $686.7 million (up 35.97% YoY) and the FY2025 annual result came in at $708.2 million, down 32.74% from the prior year.
  • Total Non-Current Liabilities was $686.7 million for Q1 2026 at Globus Medical, down from $708.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.1 billion in Q3 2023 and bottomed at $145.3 million in Q1 2022.
  • A 5-year average of $607.9 million and a median of $671.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 512.3% — and 2025, when it sank 44.5%.
  • Globus Medical's Total Non-Current Liabilities stood at $219.4 million in 2022, then jumped by 384.73% to $1.1 billion in 2023, then fell by 1.0% to $1.1 billion in 2024, then sank by 32.74% to $708.2 million in 2025, then fell by 3.04% to $686.7 million in 2026.
  • Business Quant data shows GMED's Total Non-Current Liabilities at $686.7 million in Q1 2026, $708.2 million in Q4 2025, and $671.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Globus Medical 10.21 Bn 9.58 Bn 525.79 Mn 686.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 686.67 Mn
Dec 31, 2025 708.17 Mn
Sep 30, 2025 671.73 Mn
Jun 30, 2025 560.43 Mn
Mar 31, 2025 505.03 Mn
Dec 31, 2024 1.05 Bn
Sep 30, 2024 993.66 Mn
Jun 30, 2024 992.22 Mn
Mar 31, 2024 909.94 Mn
Dec 31, 2023 1.06 Bn
Sep 30, 2023 1.15 Bn
Jun 30, 2023 162.05 Mn
Mar 31, 2023 169.92 Mn
Dec 31, 2022 219.41 Mn
Sep 30, 2022 199.80 Mn
Jun 30, 2022 147.31 Mn
Mar 31, 2022 145.29 Mn
Dec 31, 2021 203.23 Mn
Sep 30, 2021 176.43 Mn
Jun 30, 2021 142.95 Mn